PositiveID has received US Food and Drug Administration (FDA) clearance for its iglucose mobile health system for diabetes management.

The system collects and transmits stored data from several FDA-cleared blood glucose meters to a secure database using wireless cellular technology.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

PositiveID CEO William Caragol said that iglucose is a safe, flexible, convenient, cost-effective and straightforward solution that helps reduce costs to the healthcare system while improving disease management and patient compliance.

The company plans to initiate commercialisation of the device in the first quarter of 2012.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact